Comments

Eli Lilly

Q: What sector and industry does Eli Lilly (LLY) operate in?

Eli Lilly is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

LLYNYSE

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$904.97

-1.21-0.13%

At Close: -

$906.44

1.470.16%

After Hours: 7:56 PM EDT

15 minutes delayed

Eli Lilly (LLY) Forecast

News Earnings Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Overview Rating

Good

Technicals Analysis

100

0100

Financials Analysis

0100

Eli Lilly (NYSE:LLY) Stock Quotes, Forecast and News Summary

Eli Lilly Stock (NYSE: LLY) stock price, news, charts, stock research, profile.

Open	$906.31
Close	$904.97
Volume / Avg.	1.78M / 3.18M
Day Range	$903.46 - $915.50
52 Wk Range	516.57 - 972.53
Market Cap	$816.18B
P/E Ratio	111.45
Dividend Yield	0.57%
Exchange	NYSE
RSI	47
Short Interest	0.78%
Days to Cover	2.41

Recent News

Novartis Wins FDA Approval of Kisqali for Early Breast Cancer

Novartis (NYSE: NVS) announced that the FDA has approved breast cancer drug Kisqali (ribociclib) for a broader population.

Zacks

Lilly Gets FDA Approval for Eczema Drug Ebglyss

Eli Lilly and Company (NYSE: LLY) announced that the FDA has granted approval to its IL-13 inhibitor Ebglyss (lebrikizumab) for treating moderate-to-severe atopic dermatitis, also called eczema.

Zacks

Eli Lilly Scores FDA Approval For Eczema Treatment Ebglyss

The FDA has approved Eli Lilly's Ebglyss for moderate-to-severe eczema in patients 12 and older. The treatment is administered via monthly injections and demonstrated clear skin and itch relief in clinical trials.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

May

Jun

Jul

Aug

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Lilly(Eli) & Co

Sector

Health Care

Industry

Pharmaceuticals

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lill...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Eli Lilly (LLY) stock?

You can purchase shares of Eli Lilly (NYSE:LLY) through any online brokerage.

View our list of the best stock brokerages

Who are Eli Lilly (LLY) competitors?

Other companies in Eli Lilly’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

What is the forecast, or price target, for Eli Lilly (LLY) stock?

Eli Lilly has a consensus price target of $910.22.

What is the current price for Eli Lilly (LLY)?

The stock price for Eli Lilly (NYSE: LLY) is $906.44 last updated September 18, 2024 at 7:56 PM EDT.

Does Eli Lilly (LLY) pay a dividend?

A quarterly cash dividend of 1.30 per share of Class A Common Stock. The quarterly cash dividend was payable on September 10, 2024 to stockholders of record on August 15, 2024.

When is Eli Lilly (NYSE:LLY) reporting earnings?

Eli Lilly’s Q3 earnings are confirmed for Thursday, October 31, 2024.

Is Eli Lilly (LLY) going to split?

There is no upcoming split for Eli Lilly.

What sector and industry does Eli Lilly (LLY) operate in?

Eli Lilly is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

Get Our Top Trade Ideas Delivered Daily - 65% Off Now